RAB27A and breast carcinoma: Both Rab27a depletion and an nSMase2 inhibitor (GW4869) significantly inhibit the growth of breast cancer derived from 4T1 cells in mice, which is a drug-resistant model for breast cancer (Pulaski and Ostrand-Rosenberg, 2001; Lasso et al., 2019).